Crossmark Global Holdings, Inc. Teva Pharmaceutical Industries LTD Transaction History

Crossmark Global Holdings, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 13, 2021	BUY	$8.38 - $10.18 $186,463 - $226,515	22,251 Added 219.89%	32,370 $1.34 Million
Q1 2021 Apr 15, 2021	SELL	$10.34 - $12.81 $7,372 - $9,133	-713 Reduced 6.58%	10,119 $117,000
Q4 2020 Jan 14, 2021	SELL	$8.61 - $11.04 $20,793 - $26,661	-2,415 Reduced 18.23%	10,832 $105,000
Q3 2020 Oct 08, 2020	SELL	$8.57 - $12.69 $3,428 - $5,076	-400 Reduced 2.93%	13,247 $119,000
Q1 2020 Apr 28, 2020	SELL	$6.69 - $13.45 $20,912 - $42,044	-3,126 Reduced 18.64%	13,647 $122,000
Q3 2019 Oct 09, 2019	SELL	$6.16 - $9.6 $1,238 - $1,929	-201 Reduced 1.18%	16,773 $115,000
Q2 2019 Jul 09, 2019	SELL	$8.12 - $15.72 $5,781 - $11,192	-712 Reduced 4.03%	16,974 $157,000
Q2 2018 Jul 31, 2018	SELL	$16.77 - $24.71 $8,435 - $12,429	-503 Reduced 2.77%	17,686 $430,000
Q1 2018 Apr 16, 2018	SELL	$16.68 - $22.07 $10,008 - $13,242	-600 Reduced 3.19%	18,189 $311,000
Q4 2017 Feb 05, 2018	SELL	$11.23 - $19.1 $39,866 - $67,805	-3,550 Reduced 15.89%	18,789 $356,000
Q3 2016 Oct 25, 2017	BUY	N/A	22,339	22,339 $393,000

624

565M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.